X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
1st-line treatment (1) 1
adult (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
breast cancer (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - mortality (1) 1
breast neoplasms - radiotherapy (1) 1
breast neoplasms - surgery (1) 1
cancer therapies (1) 1
chemotherapy (1) 1
chemotherapy, adjuvant (1) 1
combined modality therapy (1) 1
disease-free survival (1) 1
drug dosages (1) 1
drug therapy (1) 1
efficacy (1) 1
female (1) 1
health aspects (1) 1
heart diseases - chemically induced (1) 1
her2/neu-overexpressing metastatic breast (1) 1
humans (1) 1
kinases (1) 1
mammary-carcinoma (1) 1
medicine, general & internal (1) 1
middle aged (1) 1
monoclonal-antibody (1) 1
neu oncogene (1) 1
phase-ii (1) 1
radiation therapy (1) 1
receptor (1) 1
receptor, erbb-2 - analysis (1) 1
recurrence (1) 1
safety (1) 1
surgery (1) 1
survival analysis (1) 1
therapy (1) 1
trastuzumab (1) 1
women (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2005, Volume 353, Issue 16, pp. 1659 - 1672
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.